Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Assessment of the long-term effect of vaccination on transmission of infectious bovine rhinotracheitis virus in cattle herds hyperimmunized with glycoprotein E-deleted marker vaccine.

Ampe B, Duchateau L, Speybroeck N, Berkvens D, Dupont A, Kerkhofs P, Thiry E, Dispas M.

Am J Vet Res. 2012 Nov;73(11):1787-93. doi: 10.2460/ajvr.73.11.1787.

2.

A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.

Strube W, Auer S, Block W, Heinen E, Kretzdorn D, Rodenbach C, Schmeer N.

Vet Microbiol. 1996 Nov;53(1-2):181-9.

PMID:
9011010
3.

Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.

Romera SA, Puntel M, Quattrocchi V, Del Médico Zajac P, Zamorano P, Blanco Viera J, Carrillo C, Chowdhury S, Borca MV, Sadir AM.

BMC Vet Res. 2014 Jan 8;10:8. doi: 10.1186/1746-6148-10-8.

4.

Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.

Lemaire M, Schynts F, Meyer G, Georgin JP, Baranowski E, Gabriel A, Ros C, Belák S, Thiry E.

Vaccine. 2001 Sep 14;19(32):4795-804.

PMID:
11535332
5.

An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines.

Bosch JC, Kaashoek MJ, Kroese AH, van Oirschot JT.

Vet Microbiol. 1996 Oct;52(3-4):223-34.

PMID:
8972048
6.

Dynamics of infection and immunity in a dairy cattle population undergoing an eradication programme for Infectious Bovine Rhinotracheitis (IBR).

Nardelli S, Farina G, Lucchini R, Valorz C, Moresco A, Dal Zotto R, Costanzi C.

Prev Vet Med. 2008 Jun 15;85(1-2):68-80. doi: 10.1016/j.prevetmed.2008.01.001. Epub 2008 Mar 4.

PMID:
18304663
7.

Maturation of immunoglobulin G avidity after inactive gE deleted bovine herpesvirus type 1 (BHV-1) marker vaccination.

Ozkul A, Demir B, Karaoğlu T, Alkan F, Dinçer E, Oncel T, Burgu I.

Viral Immunol. 2008 Mar;21(1):3-11. doi: 10.1089/vim.2007.0067.

PMID:
18355118
8.

[Field trials of a number of IBR vaccines in dairy cattle].

Wentink GH, van Exsel AC.

Tijdschr Diergeneeskd. 1983 May 15;108(10):392-8. Dutch.

PMID:
6308850
9.

Protection of cattle vaccinated with inactivated oil-adjuvant IBR-vaccine against experimental infection.

Zuffa A, Feketeová N.

Zentralbl Veterinarmed B. 1980;27(9-10):725-33. No abstract available.

PMID:
6261487
10.

Development of a disease control programme based on the use of an inactivated vaccine against infectious bovine rhinotracheitis.

Pospísil Z, Krejcí J, Jínek P, Lány P, Zendulková D, Cíhal P.

Vet Microbiol. 1996 Nov;53(1-2):199-206.

PMID:
9011012
11.

Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.

van Drunen Littel-van den Hurk S, Myers D, Doig PA, Karvonen B, Habermehl M, Babiuk LA, Jelinski M, Van Donkersgoed J, Schlesinger K, Rinehart C.

Can J Vet Res. 2001 Apr;65(2):81-8.

12.

An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field.

Bosch JC, De Jong MC, Franken P, Frankena K, Hage JJ, Kaashoek MJ, Maris-Veldhuis MA, Noordhuizen JP, Van der Poel WH, Verhoeff J, Weerdmeester K, Zimmer GM, Van Oirschot JT.

Vaccine. 1998 Jan-Feb;16(2-3):265-71.

PMID:
9607041
13.

Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine.

Alvarez M, Bielsa JM, Santos L, Makoschey B.

Vaccine. 2007 Sep 4;25(36):6613-7. Epub 2007 Jul 16.

PMID:
17669560
14.

Effects of on-arrival versus delayed modified live virus vaccination on health, performance, and serum infectious bovine rhinotracheitis titers of newly received beef calves.

Richeson JT, Beck PA, Gadberry MS, Gunter SA, Hess TW, Hubbell DS 3rd, Jones C.

J Anim Sci. 2008 Apr;86(4):999-1005. doi: 10.2527/jas.2007-0593. Epub 2008 Jan 11.

16.
17.

A specific PCR to differentiate between gE negative vaccine and wildtype bovine herpesvirus type 1 strains.

Schynts F, Baranowski E, Lemaire M, Thiry E.

Vet Microbiol. 1999 Apr 19;66(3):187-95.

PMID:
10227121
19.
20.

Surveillance of Infectious Bovine Rhinotracheitis in marker-vaccinated dairy herds: Application of a recombinant gE ELISA on bulk milk samples.

Muratore E, Bertolotti L, Nogarol C, Caruso C, Lucchese L, Iotti B, Ariello D, Moresco A, Masoero L, Nardelli S, Rosati S.

Vet Immunol Immunopathol. 2017 Mar;185:1-6. doi: 10.1016/j.vetimm.2017.01.003. Epub 2017 Jan 24.

Supplemental Content

Support Center